Steriwave Now Protecting Patients with Cancer The Mater Hospital, North Sydney, Adopts Steriwave to Combat AMR in Cancer Care Antimicrobial resistance (AMR) is driving higher mortality, morbidity, and healthcare costs for patients with cancer. Hospitalized patients with cancer face up to twice the risk of antibiotic-resistant infections. AMR pathogens are [...]

Ondine Presents Major Economic Benefits at ICPIC Analysis Presented at ICPIC 2025 Highlight Benefits of Steriwave Nasal Photodisinfection in Head-to-Head Comparisons with Octenisan and Mupirocin   70% SSI reduction in hip and knee arthroplasties using Steriwave at Mid Yorkshire Hospitals NHS Trust compared to using Octenisan nasal gel alone. 52% [...]

Steriwave Effective Against C. auris C. auris drug resistant fungus has increased by 67% in EU Hospitals year on year VANCOUVER, B.C.— According to a new report this month from the European Centre for Disease Prevention and Control (ECDC) cases of Candidozyma auris (C. auris) formerly known as Candida auris, [...]

Steriwave Featured on CNBC’s Worldwide Exchange Ondine Biomedical Inc. (AIM: OBI), a Canadian life sciences company pioneering light-activated, non-antibiotic infection prevention therapies, announces that its Steriwave® nasal photodisinfection technology received international media attention when it was highlighted yesterday on CNBC’s Worldwide Exchange by former President of Mexico, Vicente Fox. During the interview, Mr. [...]